Ravi Anchoori

Pilot corpus only

This score is computed over theSindex pilot corpus and does not cover the full scientific literature. Scores are relative to papers we have ingested — papers, authors, and institutions outside the pilot are not represented. Methodology.

Top 100%percentile

0Author DataRank

Indexed papers

0in pilot corpus

datarank_citation_only_1hop_v6· scope data_onlyMethodology

Papers

Driven by 7 papers. Top paper: “Bis-benzylidine Piperidone RA190 treatment of hepatocellular carcinoma via binding RPN13 and inhibiting NF-κB signaling”.

Bis-benzylidine Piperidone RA190 treatment of hepatocellular carcinoma via binding RPN13 and inhibiting NF-κB signaling

BMC Cancer(2020)10.1186/s12885-020-06896-0

N/A

0DataRank · unranked

20 citations

Ravi Anchoori, Richard B.S. Roden, Rou‐Ling Cho, Yi-Chan Chen, Sheng-Chieh Tseng +4 more

Structure-function analyses of candidate small molecule RPN13 inhibitors with antitumor properties

PLoS ONE(2020)10.1371/journal.pone.0227727

N/A

0DataRank · unranked

15 citations

Marietta Tan, Ssu-Hsueh Tseng, Shiwen Peng, Ruey-Shyang Soong, Aliyah Algethami +8 more

Bis-benzylidine Piperidone RA190 Treatment of Hepatocellular Carcinoma via Binding RPN13 and Inhibiting NF-κB Signaling

Research Square(2020)10.21203/rs.2.18702/v4

N/A

0DataRank · unranked

0 citations

Ravi Anchoori, Richard B.S. Roden, Rou‐Ling Cho, Yi-Chan Chen, Sheng-Chieh Tseng +4 more

Bis-benzylidine Piperidone RA190 Treatment of Hepatocellular Carcinoma via Binding RPN13 and Inhibiting NF-κB Signaling

Research Square(2020)10.21203/rs.2.18702/v3

N/A

0DataRank · unranked

0 citations

Ravi Anchoori, Richard B.S. Roden, Rou‐Ling Cho, Yi-Chan Chen, Sheng-Chieh Tseng +4 more

Chirality and asymmetry increase the potency of candidate ADRM1/RPN13 inhibitors

PLoS ONE(2021)10.1371/journal.pone.0256937

N/A

0DataRank · unranked

10 citations

Logan George, Ssu-Hsueh Tseng, Brandon Lam, Srinidhi Polkampally, Anjali D. Amiano +11 more

Development and anticancer properties of Up284, a spirocyclic candidate ADRM1/RPN13 inhibitor

PLoS ONE(2023)10.1371/journal.pone.0285221

N/A

0DataRank · unranked

4 citations

Vidyasagar Anchoori, Brandon Lam, Ssu-Hsueh Tseng, Samarjit Das, Fernanda Carrizo Velásquez +7 more

Preclinical studies of RA475, a guanidine-substituted spirocyclic candidate RPN13/ADRM1 inhibitor for treatment of ovarian cancer

PLoS ONE(2024)10.1371/journal.pone.0305710

N/A

0DataRank · unranked

1 citations

Ssu-Hsueh Tseng, Hua-Ling Tsai, Vikrant Palande, Michelle A. Rudek, Richard B.S. Roden +1 more